Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers Podcast Por Dexcom arte de portada

Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers

Real-Time Real Talk | Continuous Glucose Monitoring (CGM) Education for Healthcare Providers

De: Dexcom
Escúchala gratis

OFERTA POR TIEMPO LIMITADO. Obtén 3 meses por US$0.99 al mes. Obtén esta oferta.
Enhancing diabetes care with real-time continuous glucose monitoring (CGM) is the focus of Real-Time Real Talk, the go-to podcast for healthcare professionals in the U.S. Whether you're an endocrinologist, primary care physician, diabetes educator, or pharmacist, this show provides expert insights and real-world applications to help you optimize patient outcomes with CGM technology. Each month, Real-Time Real Talk brings you in-depth conversations with leading clinicians, researchers, and industry experts, diving into: How to integrate real-time CGM into your practice – Learn best practices for onboarding patients and interpreting CGM data The latest clinical evidence – Explore groundbreaking studies on real-time CGM and its impact on glucose tracking Real-world success stories – Hear firsthand experiences from healthcare providers and patients using Dexcom G7 and Stelo to manage type 1 diabetes, type 2 diabetes and prediabetes. Episode topics have included: Type 2 Diabetes Management Through Glucose Tracking: How CGM Improves Patient Outcomes with Dr. Thomas Grace and Dr. William Polonsky Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes with Emily Cornelius, Registered Dietitian Empowering Diabetes Care: Revolutionizing Hospital Discharge Planning with CGM Technology with David Tulle Real-Time Real Talk is your trusted source for staying up to date on CGM advancements. Hosted by Cher Pastore (MS, RD, CDCES, BC-ADM), she is a registered dietitian and certified diabetes care and education specialist, holding a Master of Science in Nutrition from New York University and a Bachelor of Arts in Psychology from University of Massachusetts Boston. She is also a Director of clinical education at Dexcom. Prior to joining Dexcom, Cher was in clinical practice for more than 10 years, specializing in diabetes technology. While in practice, she developed a love of using CGM as a tool in diabetes care. Cher has been featured in such publications as People, D-Life, Everyday Health, and Diabetes Daily, and has appeared in broadcasts on SiriusXM, Extra TV, Channel 5, Channel 7 News. Now, she's excited to share her expertise on a medical podcast. Dexcom is a leader in real-time CGM technology, empowering patients and healthcare providers with accurate, real-time glucose insights. Dexcom has won more than 20 awards over the last 2 years including: 2025 CES Innovation Award Honoree 2023 Healthcare Marketing Impact Award - Film/TV/Video Campaign of the Year ◦ Dexcom Super Bowl Commercial with Nick Jonas and everyday ‘warriors’ 2024 German Design Award – Dexcom G7 CGM System Learn more at dexcom.com. Want to get involved with the show? You can reach us at Cher.pastore@dexcom.com to: Bring Dexcom to your event Be a guest on the show Ask Cher a question If you like Diabetes Core Update, Juicebox Podcast: Type 1 Diabetes, The Huddle: Conversations with the Diabetes Care Team, you’ll enjoy Real-Time Real Talk.Copyright 2024 All rights reserved. Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Exploring the Barriers and Future of Diabetes Technology: Why Continuous Glucose Monitoring (CGM) is Gaining Traction - Recorded Live at the American Diabetes Association conference (ADA)

    Exploring the Barriers and Future of Diabetes Technology: Why Continuous Glucose Monitoring (CGM) is Gaining Traction - Recorded Live at the American Diabetes Association conference (ADA)
    Sep 23 2025
    Only 1 in 5 people with type 2 diabetes on insulin use Continuous Glucose Monitoring (CGM) and for those not on insulin, that number drops to just 5%. With real-time glucose tracking transforming how patients understand and manage their health, why isn’t CGM more widely used? In this live episode from the American Diabetes Association (ADA) Conference, Real-Time Real Talk explores the barriers, breakthroughs, and future of diabetes technology. You'll hear why CGM is gaining traction not just for type 1 diabetes, but also in primary care, prediabetes, and even among the glucose-curious. -- Disclaimer: This podcast is not approved for CME credit. Every diabetes treatment plan is different, individual results may vary – nothing you hear on this podcast should be considered medical advice. All claims are supported by clinical evidence referenced in the show notes. For clinical study results, please refer to the Dexcom G7 User Guide. For product-related questions, please refer to the instructions for use. For complete safety information, go to dexcom.com/safety-information. Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility. “Dexcom" refers to the Dexcom CGM. Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7. The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy. G7 15 Day is only for adults 18+. This guest is a paid spokesperson for Dexcom. Brief Safety Statement: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom, Dexcom Follow, Dexcom Clarity, and Dexcom Share are registered trademarks of Dexcom, Inc. in the U.S., and may be registered in other countries. STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency. Patient results may vary.
 MAT-9989
    Más Menos
    31 m
  • Lance Bass Shares his Journey with Diabetes Including his Misdiagnosis of Type 2 Diabetes: How Continuous Glucose Monitoring Helped Lance Bass Take Control of his Health

    Lance Bass Shares his Journey with Diabetes Including his Misdiagnosis of Type 2 Diabetes: How Continuous Glucose Monitoring Helped Lance Bass Take Control of his Health
    Aug 26 2025
    Lance Bass discusses an honest look at misdiagnosis, diabetes stigma, and how real-time Continuous Glucose Monitoring (CGM) transformed his life on this special episode of Real-Time Real Talk recorded live at the American Diabetes Association conference (ADA) in Chicago this June. When Lance was first diagnosed with type 2 diabetes, it didn’t make sense - he ate well, exercised, and didn’t fit the typical profile. But as his glucose remained high and symptoms worsened, he discovered he actually had LADA (Latent Autoimmune Diabetes in Adults), a slow-progressing form of type 1 diabetes. Host Cher Pastore, MS, RD, CDCES, BC-ADM sits down with Lance to unpack his journey from misdiagnosis to managing his condition with CGM and advanced diabetes technology. Lance shares how CGM with the Dexcom G7 transformed his diabetes management, allowing him to see blood sugar levels in real time, avoid dangerous lows, and personalize his food and insulin decisions. They discuss everything from automated insulin delivery systems to blood sugar monitoring tips, glucose sensors, and the mental relief that comes from not having to guess what’s happening in your body. He also opens up about raising awareness, reducing stigma for young people with diabetes, and why showing his G7 publicly has helped others feel seen and supported. Whether you're a healthcare provider, parent, or person living with diabetes, this episode offers powerful insight into the life-changing potential of CGM technology and is a must-listen for anyone affected by type 1 diabetes, type 2 diabetes, or prediabetes - including patients, endocrinologists, and primary care providers. The interview offers an honest and insightful look at how biosensor tools like CGM are reshaping diabetes treatment, diabetes education, and metabolic health outcomes.
    Más Menos
    16 m
  • Why Continuous Glucose Monitoring Is Crucial for People with Diabetes Not Using Insulin

    Why Continuous Glucose Monitoring Is Crucial for People with Diabetes Not Using Insulin
    Jul 21 2025
    Even for those not on insulin, Continuous Glucose Monitoring (CGM) is transforming the way HCPs approach diabetes treatment. Cher Pastore, MS, RD, CDCES, BC-ADM and guest David Doriguzzi, a Physician Assistant in endocrinology and internal medicine explore how Dexcom G7 and Stelo are reshaping diabetes management for people with type 1 diabetes, type 2 diabetes, and prediabetes. Together, they break down how Dexcom’s portfolio provides real-time glucose monitoring, reveals patterns invisible through traditional blood sugar monitoring, and inspire meaningful behavior change. David shares patient stories that demonstrate how CGM is helping individuals recognize how food, activity and medications impact their diabetes management. He also explains how CGM empowers providers to tailor diabetes education and medication strategies, especially in primary care settings with limited access to endocrinologists. Whether you’re managing type 1 diabetes, type 2 diabetes or on the journey to prevent it, this conversation showcases how diabetes technology like CGM can simplify treatment decisions, personalize care, and ultimately make an impact for both patients and providers.
    Más Menos
    38 m
Todavía no hay opiniones